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Abstract
Background: Posttraumatic stress disorder (PTSD) is a debilitating anxiety disorder. Surveys of the general
population suggest that while 50-85% of Americans will experience a traumatic event in their lifetime, only 2-50%
will develop PTSD. Why some individuals develop PTSD following trauma exposure while others remain resilient is a
central question in the field of trauma research. For more than half a century, the role of genetic influences on
PTSD has been considered as a potential vulnerability factor. However, despite the exponential growth of molecular
genetic studies over the past decade, limited progress has been made in identifying true genetic variants for PTSD.
Methods: In an attempt to aid future genome wide association studies (GWAS), this paper presents a systematic
review of 28 genetic association studies of PTSD. Inclusion criteria required that 1) all participants were exposed to
Criterion A traumatic events, 2) polymorphisms of relevant genes were genotyped and assessed in relation to
participants’ PTSD status, 3) quantitative methods were used, and 4) articles were published in English and in
peer-reviewed journals. In the examination of these 28 studies, particular attention was given to variables related to
trauma exposure (e.g. number of traumas, type of trauma).
Results: Results indicated that most articles did not report on the GxE interaction in the context of PTSD or present
data on the main effects of E despite having data available. Furthermore, some studies that did consider the GxE
interaction had significant findings, underscoring the importance of examining how genotypes can modify the
effect of trauma on PTSD. Additionally, results indicated that only a small number of genes continue to be studied
and that there were marked differences in methodologies across studies, which subsequently limited robust
conclusions.
Conclusions: As trauma exposure is a necessary condition for the PTSD diagnosis, this paper identifies gaps in the
current literature as well as provides recommendations for how future GWAS studies can most effectively
incorporate trauma exposure data in both the design and analysis phases of studies.
Keywords: Posttraumatic stress disorder, Trauma, Genetics, Genome-wide association studies, Gene–environment
interaction
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Post-traumatic stress disorder (PTSD) occurs following
exposure to a traumatic event and is defined by distinct
symptom clusters of re-experiencing, avoidance and
numbing, and arousal persisting for more than 1 month
after trauma [1]. At least 1 in 9 American women and 1
in 20 American men will meet criteria for the diagnosis
in their lifetime [2,3]. Among the 50% to 85% of Americans
who are exposed to a traumatic event, the conditional risk
of PTSD ranges from 2% to 50% [3-5]. Why some indivi-
duals develop PTSD following trauma exposure while
others are resilient remains a key question in trauma re-
search. The importance of genetic influences on PTSD risk
have been recognized for half a century [6] and heritability
estimates range from approximately 30 – 70% [7-9].
However, the first molecular genetic study of PTSD was
not published until 1991 [10]. Limited progress has
been made in identifying true or causal genetic variants
for PTSD despite the fact that the number of molecular
genetic studies of PTSD has grown exponentially in the
past decade (Figure 1). Elsewhere, we have reviewed the
state and limitations of genetic research on PTSD. We
have discussed how these limitations can be addressed
through genome-wide association studies (GWAS),
which combined with well-powered replication samples,
offer the best opportunity to identify novel “true” risk
variants for the disorder [11]. Large-scale GWAS of
PTSD are now underway.
This paper presents a systematic review of molecular
genetic studies of PTSD to identify the characteristics of
trauma exposure that may be most important to con-
sider in GWAS studies of PTSD. Because trauma expos-
ure is a necessary condition for a PTSD diagnosis,
GWAS studies of PTSD will need to contend with how
to make best use of trauma exposure data in both the
design and analysis phases of their studies. In doing so,
GWAS of PTSD will be delving into uncharted territory.
Several approaches for examining GxE in the context of
GWAS have been proposed [12-14]. However, GWAS of
psychiatric disorders have thus far not included consid-
eration of environmental risk factors. This is true even
of GWAS for major depression [15-21], where the con-
tribution of environmental determinants such as stress-
ful life events [22] has been well-established. In fact, the
authors of a recent mega-analysis of GWAS in major de-
pression concluded, “It is possible that MDD can only
be understood if genetic and environmental risk factors
are modeled simultaneously (pg. 7)” [23].
Informed by this observation, we thus focused on the
most salient design and analysis considerations for
GWAS of PTSD. In particular, we focused on extracting
information related to three trauma characteristics most
known to be associated with PTSD risk. We assessed
how these variables were considered in previous studies
and how such consideration influenced the study find-
ings. First is the type of trauma, as the conditional risk
of PTSD varies by event. For example, assaultive vio-
lence events tend to have the general highest conditional
risk of PTSD [24]. Based on gender, combat exposure
for men, and rape and sexual molestation for women are
the event types most strongly associated with PTSD
onset [3]. Second, we focused on the number of traumas.
Research has indicated that prior exposure to trauma
creates greater risk of PTSD from subsequent trauma
[4]. Third, we focused on how long ago the traumatic
event took place and where the event(s) occurred along
the developmental continuum (i.e., whether it occurred
in childhood or adulthood). There is evidence to suggest
that abuse experienced during childhood places indivi-
duals at greatest risk for the development of psychopath-
ology, including PTSD, as adults [25,26].
Methods
The systematic review was based on articles found in
PubMed, PsycINFO and Published International Litera-
ture on Traumatic Stress (PILOTS). Inclusion criteria
required that 1) all participants were exposed to Criter-
ion A traumatic events, 2) polymorphisms of relevant
genes were genotyped and assessed in relation to partici-
pants’ PTSD status, 3) quantitative methods were used,
and 4) articles were published in English and in peer-
reviewed journals. Search terms were based on descrip-
tor headings, which are selected by each of the databases
to best describe the subject of the articles. Terms
included: posttraumatic stress disorder, PTSD, genetics,
and behavioral genetics. Boolean methods were also used
in order to find articles that combined the subjects of
PTSD and genetics. Although publication date was not
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clusion criteria.
In addition to sample size and demographic character-
istics, the following information was extracted from each
article that met our inclusion criteria: the type of trauma
and whether it occurred in childhood or adulthood, the
time since the trauma, whether multiple traumas were
assessed and considered in the analysis, and the major
findings.
Results
A total of 28 articles met inclusion criteria (Table 1).
The sample sizes ranged widely from N=40 to 2,427.
In fact, seven studies (25%) had sample sizes less than
100 and an additional 14 (50%) had samples between
100 and 500.
Age
Out of 28 studies, 20 provided age information for both
trauma and control groups. Of the studies reporting age,
only two focused on child trauma with child PTSD
symptoms, with one study focusing on preschoolers who
lived through Hurricane Katrina [27] and the other fo-
cusing on adolescents who were hospitalized following
physical injury [28]. Four studies examined the effects of
either 1) the combination of either childhood or adult
trauma on adult PTSD or 2) only childhood trauma on
adult PTSD. The remaining 22 articles had exclusively
adult samples. The adult samples largely had a mean age
ranging from 33.9 to 57.6. The exception were two arti-
cles on the 2004 Florida Hurricane, which focused on an
older adult population; in both these studies more than
76% were over 60 years of age [29,30]. It is difficult to
make meaningful comparisons between the results of
child vs. adult studies as there are only two studies that
focused exclusively on child trauma and its effect on
child PTSD. The outcome variable for the remaining
studies was adult PTSD.
Ethnicity
Of studies that reported racial/ethnic information, 56%
of the participants were Caucasians, 42% were African
American and 2% were classified as Other (e.g., Latino,
Asian).
Measurement of environment (i.e., trauma)
Measurement of trauma varied considerably across stud-
ies. There were substantial discrepancies in how trauma
was measured in terms of quantity, timing and type. For
example, 13 studies had samples that were traumatized
multiple times. Of these, eight found a significant GxE
interaction, while only one did not; the four remaining
studies did not report on the GxE interaction. Further-
more, the majority of articles did not examine the main
effect of trauma on PTSD. Out of the 28 articles, 17 arti-
cles reported if there was a main effect of trauma on
PTSD. Of those, 12 found a significant main effect for
trauma (Figure 2).
Primary trauma type
The level of information provided about the type of pri-
mary trauma varied. Four (14%) of the articles selected
samples based on exposure to a specific traumatic event
such as a natural disaster or physical injury resulting in
medical care. For these four studies, all participants had
experienced the same traumatic stressor. However, the
remaining 24 (86%) articles were studies of community-
based samples exposed to a range of traumatic events.
Of the articles on adult samples, only 2 (7%) considered
events that occurred in both childhood and adulthood
as the primary types of trauma. All four studies that
examined child abuse/adversity as the primary trauma
type found a significant GxE interaction. Likewise, the
two studies that examined the Rwandan genocide, and
the two studies that studied the Florida hurricanes found
a significant GxE interaction.
Time since the trauma
Information about the amount of time that had elapsed
since the traumatic event was provided by 9 (31%) of the
articles and, therefore, not included in Table 1. The arti-
cles that reported this information typically selected par-
ticipants based on exposure to a one specific event, such
as the 2004 Florida Hurricane Study, Polish flood, Rwan-
dan genocide, or recruited participants following a spe-
cific type of event, such as physical injury requiring
hospitalization. For the majority of these studies, the
index trauma occurred within a year of assessment. The
exception to this was the studies of Rwandan genocide
survivors; the genocide occurred approximately 12 years
prior to assessment.
Measurement of phenotype
Only 18 articles reported whether participants had
current or lifetime PTSD. Of those, seven examined only
participants who had current PTSD. Of the studies that
reported on lifetime PTSD status and the GxE inter-
action, all but one found a significant GxE relationship.
Of the six studies that assessed for current PTSD, three
found a significant GxE interaction.
Measurement of genotype and neurobiological system
All 28 studies assessed for the main effect of gene(s),
with 14 studies reporting a significant finding (Figure 2).
Within these 28 studies, a total of 14 distinct genes were
examined. However, 64.3% of studies focused on the role
of four genes: SLC6A4, DAT1, DRD2, and FKBP5. Exam-
ples of other genes examined included DRD4 and GCCR
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Reference
(year)
Sample
size (%
PTSD
Cases)
a
Mean age (SD) Race Primary trauma
type
Issue of
multiple
traumas
addressed?
Gene Significant
main
effect of
trauma?
Significant
main
effect of
gene?
GxE
interaction?
General conclusions
Studies of Child Trauma on Child PTSD (2)
Amstadter
et al.
(2011)
103;
PTSD-RI
M= 24.09
(12.2)
14.63 (3.2) 40.8% EA;
45.6% AA;
13.6% O
Physical injury NR
b CRHR1 Yes Yes NR rs12944712 was significantly related to higher
acute PTSD Sxs and increasing trajectory of Sxs
over time.
Drury et al.
(2009)
88 (NR) 3-6(NR) 56% AA; 40%
EA
Hurricane Katrina NR DAT1 NR Yes NR The 9 allele increased risk of PTSD—both in the
form of total and Criterion D Sxs.
Studies of Adults with History of Child and/or Adult Trauma on Adult PTSD (4)
Binder
et al.
(2008)`
900
c 40.8 (13.8) 95.2% AA; Child abuse and
non-child abuse
Yes FKBP5 Yes No Yes Significant interaction between FKBP5
polymorphisms and child abuse found for adult
PTSD Sxs. The interaction for adult trauma was
not significant.
2.2% EA;
0.6% L;
0.1% A;
0.9% Mixed;
1.0% Other
Nelson
et al.
(2009)
259
(17.8%
LT)
NR NR Child abuse NR GABRA2 NR No Yes Interactions b/w child trauma and SNP genotype
provide consistent support for GxE interactions
involving child trauma and SNP genotype. When
separate variables were coded for the presence
of one or two risk-associated alleles, significant
Gx E interactions are only found for homozygous
individuals.
Xie et al.
(2010)
2427
(14.0%
LT)
38.6 (10.8) 47.1% EA;
52.9% AA
Child adversity Yes FKBP5 Yes No Yes In AAs, the interaction between child adversity
and all 4 FKBP5 SNPs were associated with PTSD.
SNP rs9470080 had strongest conditional effect;
for AAs without child adversity, those
homozygous for T allele had lowest risk of PTSD,
while homogygotes with adversity had highest
risk.
Xie et al.
(2009)
1252
(18.3%
LT)
38.9( 11) 46.5% EA;
53.5% AA
Both Yes SLC6A4 Yes No Yes 5-HTTLPR polymorphism alone did not predict
PTSD; however it interacted with adult traumatic
events and child adversity to increase the risk for
PTSD, especially for those with high rates of
both types of trauma exposure.
Studies of Adults which Assessed Adult Trauma (22)
Amstadter
et al.
(2009)
607
(3.6%)
22.6% ≤ 59 90% EA; 3.9%
AA; 3.9% L;
1.7% Other;
0.5% Missing
2004 FL hurricanes Yes RGS2 No No Yes GxE interaction such that rs4606 moderated risk
of PTSD Sxs under high E stress and low social
support. Both LT
and CT
Sxs
asses’d
77.4% ≥ 60
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2Table 1 Demographic information, results and conclusions for GxE Studies of PTSD (Continued)
Kolassa
et al.
(2010a)
424
(80.2% LT;
48.8% CT)
34.8 (5.8) 100% Hutu or
Tutsi
Rwandan
genocide
Yes COMT Yes, LT
PTSD
No, for LT
and CT
PTSD
Yes, LT PTSD COMT genotype affected PTSD such that met/
met homozygotes had higher risk for PTSD than
those with Val allele independent of severity of
traumatic load.
No, CT
PTSD
No, CT PTSD
Kolassa
et al.
(2010b)
408
(81.1%
LT)
34.68 (5.9)1 0 0 %
Rwandan
refugees
Rwandan
genocide
Yes SLC6A4 Yes , LT
PTSD
Yes , LT
PTSD
Yes , LT
PTSD
Probability of developing PTSD was 100% for s
homozygotes and there was no dose–response
relationship between trauma and PTSD.
However, when trauma approached extreme
levels, genotype effect disappeared and PTSD
approached 100%.
Kilpatrick
et al.
(2007)
589 (3.2%
CT)
22.6%≤ 59 90% EA; 3.9%
AA; 3.9% L;
1.7% Other;
0.5% Missing
2004 FL hurricanes Yes SLC6A4 No No Yes 5-HTTLPR increased risk of PTSD under low social
support condition. 76.6% ≥ 60
Thakur
et al.
(2009)
41 (59%
“acute”
PTSD)
32 (NR) 95% EA; 5%
Other
MVA
d Yes SLC6A4 NR Yes NR Higher chronic PTSD was found in ll genotypes
than sl and ss genotypes.
Dragan al.
(2009)
107
(22.4%
CT)
35.57 (12.89) NR Polish flood Yes DRD4 Yes Yes No At least 1 copy of DRD4 long allele related to
higher total PTSD and Avoidance/Numbing Sxs.
Comings
et al.
(1996)
56 (66%*) 43.6 (NR) 100% EA Vietnam War No DRD2 NR Yes NR 59.5% of those with PTSD had D2A1 allele; of the
group that did not have PTSD, only 5.3% had
D2A1 allele.
Bachmann
et al.
(2005)
160
(73.8%*)
55.7 (4.2) NR Vietnam War No GCCR NR No NR N363S and Bcll GR polymorphisms not more
frequent in PTSD patients than controls.
Gelernter
et al.
(1999)
139
(37.4%*)
With PTSD: 44.6 (3.6) 100% EA Vietnam War No DRD2 NR No NR No allelic association between DRD2 TaqI “A”
system alleles and PTSD. Without PTSD: NR
Grabe et al.
(2009)
1,663
(4.03%
LT)
With ≥ 1 traumatic
experience: 57.6
(15.6); without
traumatic
experience: 50.0
(13.3)
100% EA Community based
sample; variety of
events
Yes SLC6A4 Yes Yes Yes GxE interaction found between high expression
of LA allele and frequent trauma.
Koenen
et al.
(2009)
590 (3.2%
CT)
<60 = 22.7% 90.7% EA;
9.5% Other
2004 FL hurricanes NR SLC6A4 Yes No Yes County-level crime and employment rate
modified association between genotype and
PTSD risk. The s’ allele associated with decreased
risk in low-risk environments and increased risk
in high-risk environments.
Mellman
et al.
(2009)
118 (47%
LT)
39.9(16.3) NR Various NR SLC6A4 NR Yes NR 5HT2A G allele significantly associated with PTSD.
Mustapic
et al.
(2007)
167 (85%
CT and
LT)
With PTSD: 40.3
(7.2); Without PTSD
38.12 (4.2)
100% Croatian
Caucasian
Combat-related
trauma
No DBH NR Yes NR PTSD associated with significantly lower plasma
DBH activity in those carrying CC genotype.
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2Table 1 Demographic information, results and conclusions for GxE Studies of PTSD (Continued)
Sayin et al.
(2010)
77 (23.3%
CT and
50.0% LT)
NR NR Mild physical
trauma
NR SLC6A4 Yes No No Having L allele for 5-HTT gene- linked
polymorphic region may cause milder
hyperarousal symptoms in those patients who
have developed PTSD.
Segman
et al.
(2002)
206
(50.5%
CT)
With PTSD: 39.7
(11.7); Without PTSD:
33.9 (10.2)
100% Jewish
of definite
Ashkenazi or
non-Ashkenazi
origin
Various (e.g., road
accidents,
terrorism)
NR DAT1 NR Yes NR The nine repeat allele at the DAT1 locus
associated with increased risk for PTSD.
Bailey et al.
(2010)
200
(36.5%*
e)
NR 100%
Armenian
1988 Armenian
Earthquake
NR DRD2,
DAT1
NR No NR Neither DRD2 nor DAT1 associated with PTSD.
Sarapas
et al.
(2011)
40 (50%
total;
both CT
and LT
assessed)
With PTSD: 57.30
(13.2); Without PTSD:
51.20 (15.9)
100% EA 9/11 attacks Yes FKBP5 Yes, child
trauma
No NR Comparison of LT versus CT PTSD identified
overlapping genes with altered expression
suggesting enduring markers, while some
markers present only in CT PTSD may reflect
state measures. As a follow-up, direct
comparisons of expression in CT PTSD, LT-only
PTSD, and control groups identified FKBP5 and
MHC Class II as state markers, and also identified
several trait markers. An analysis of indirect
effects revealed that homozygosity for any of 4
PTSD risk-related polymorphisms at FKBP5
predicted FKBP5 expression, which mediated
indirect effects of genotype on plasma cortisol
and PTSD severity.
Yes, other
trauma
Valente
et al.
(2011a)
99
(66.5%*)
With PTSD: 37.9
(8.7); Without PTSD:
44 (13.8)
NR Urban violence Yes COMT No, child
trauma
Yes NR Found significant association (between met allele
and PTSD in victims of violence
Valente
et al.
(2011b)
99
(66.5%*)
With PTSD: 37.9
(8.7); Without PTSD:
44 (13.8)
NR Being victim of an
urban violence
that could be
characterized as
criterion A
Yes BDNF,
DAT1,
SLC6A4
No Yes, DAT1 NR Only the nine repeat allele of the DAT1 was
associated with an increased risk of PTSD after
being exposed to urban violence.
No, SLC6A4
Hauer et al.
(2011)
126
(11.9%
CT)
Homozygotes: 67.1
(10.8); Heterozygotes:
65.8(9.3)
NR Cardiac surgery NR GCCR No Yes NR Homozygous Bcll *G carriers at an increased risk
for PTSD stress.
Ressler
et al.
(2011)
NR NR Majority AA NR NR PACAP,
PAC1
NR Yes,
women
only
NR Alterations in the PACAP–PAC1 pathway involved
in abnormal and sex-specific stress responses
underlying PTSD. These sex-specific effects may
occur via oestrogen regulation of ADCYAP1R1.
Tang et al.
(2010)
227
(30.4%
CT)
43.9 (12.8)1 0 0 % A A N R N R DBH ME for
adult; No
ME for child
No NR No relationship between sDβH and PTSD (i.e., Sx
or Dx)
a In the absence of information on percentage of PTSD in sample, M(SD) of PTSD symptoms provided, when available.
b NR = Not reported.
c Overall M(SD) not reported.
d MVA = Motor vehicle accident.
e* = Authors did not distinguish between lifetime (LT) and current (CT) PTSD.
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2(See Figure 3 for more examples). Of the 14 genes exam-
ined, the majority related to the functioning HPA axis,
dopaminergic and serotonergic systems. In recent years,
genes involved in the HPA axis and the regulation of
other neurobiological pathways have received the most
attention (Figure 3).
GxE Findings
Of the studies that examined the statistical relationship
between GxE, 10 of the studies reported a significant
GxE interaction (Figure 2). Neither of the two studies
that had samples entirely comprised of children reported
on the statistical GxE relationship, whereas all four of
the studies that explored the combined effects of child
and adult trauma found a significant interaction. Of the
studies that explored the GxE interaction, a significant
relationship was found in nine of the studies that exam-
ined SLC6A4, four for DAT1, three for DRD2 and three
for FKPB5. Out of the 28 studies, 16 did not report on
the statistical GxE relationship. Also, none of the genes
that was explored by multiple studies contained infor-
mation about the GxE relationship in all of the studies
in which it was explored. For example, although FKBP5
was examined in three studies, only two of these three
studies explored the GxE relationship [31-33]. Moreover,
some of the most explored genes (i.e., DRD2) have no
information in any of the articles about the statistical
interaction between GxE.
Conclusions
General conclusions
We systematically reviewed genetic studies of PTSD to
identify the most important characteristics of trauma ex-
posure to consider in future GWAS of PTSD. Although
we [11,34-36] and others [37-39] have previously
reviewed genetic studies of PTSD, this is the first review
to explicitly emphasize the GxE relationship. Our review
of the 28 available genetic association studies leads to
four central conclusions.
First, although the data were often available, most arti-
cles did not report on the GxE interaction in the context
of PTSD or present data on the main effects of E. Out of
28 studies, only 12 analyzed this interaction, with 10
finding a significant GxE relationship (Figure 2).
Although all 28 articles reported the main effect of gene
on PTSD, only 17 reported on the main effect of trauma.
In the 16 articles that did not examine the GxE inter-
action, the authors focused solely on the results for the
putatively relevant genetic loci. For example, one study
examined no interactions and only sought to examine
the main effect of gene on PTSD [40]. Similar analytic
strategies were used in numerous other studies [41-43].
The lack of systematically presented information on
main effect of trauma exposure makes it challenging to
reach substantive conclusions about GxE interactions in
PTSD based on extant studies.
Second, other studies highlight the importance of con-
sidering the GxE interaction when exploring PTSD’s eti-
ology [32]. One study [32] found that in an African
American sample, the nature of the interaction between
childhood adversity and FKBP5 SNPs on the develop-
ment of PTSD depended on environmental conditions.
Specifically, for African Americans without child abuse,
those homozygous for T allele of rs9470080 had the low-
est chance of developing PTSD. Conversely, however,
homozygotes for the same allele who had experienced
child abuse had highest risk of developing PTSD. Other
studies also found no main genetic effect but found a
significant GxE effect on PTSD [29]. Such studies under-
score how analysis of the GxE relationship is imperative
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14 genes DRD2
DAT1
DRD4
SLC6A4
FKBP5
GCCR
COMT
DBH
Other
Figure 3 Genes examined by percentage.
DiGangi et al. Biology of Mood & Anxiety Disorders 2013, 3:2 Page 7 of 12
http://www.biolmoodanxietydisord.com/content/3/1/2for gaining a more robust understanding of PTSD’s
pathogenesis. Although these findings raise important
questions for future research, there is presently insuffi-
cient evidence to draw broad conclusions about how
genotypes modify the effect of trauma on PTSD.
Third, although molecular genetic studies of PTSD
date back to 1991 [10], our review indicated that only a
small number of genes have been studied. Across this
body of 28 studies, a total of 14 distinct genes have been
examined. In 2010, Cornelis and colleagues [11] pub-
lished a review of genetic research on PTSD. Our review
builds on this earlier paper in that it not only includes
articles published after 2010, but additionally—and un-
like the Cornelis review—only includes studies where
both the PTSD and non-PSTD controls were trauma
exposed. Since the publication of the Cornelis and col-
leagues’ review, a total of nine new studies met our cri-
teria and were included. Of all studies reviewed, 64.3%
of studies focused on the role of four genes: SLC6A4,
DAT1, DRD2, and FKBP5 [33,44-46]. Since the Cornelis
review, only three additional genes have been examined.
These include: CRHR1 [28], GCCR [47], and PACAP
[48]. The neurobiological systems that these 14 genes
play a role in regulating involve the HPA axis, dopamin-
ergic and serotonergic systems. Interestingly, none of the
nine new studies focused on the dopaminergic and sero-
tonergic systems; all focused on the HPA axis and other
neurobiological pathways (Figure 1). Although there
have been intensive research efforts during the past few
decades, the state of the literature remains too prelimin-
ary to make substantive conclusions on how genes influ-
ence PTSD. As we continue to examine the genetic
mechanisms underlying PTSD’s etiology, it is believed
that GWAS studies will be an important step forward in
this process.
GWAS allows for a comprehensive scan of the genetic
risk landscape in an unbiased manner that is untethered
to the more traditional and literature-based selection
of candidate genes. Thus, GWAS provides a critical
hypothesis-generating tool in the identification of genes
previously unrecognized in the etiology of PTSD. As the
study of genetic risk in PTSD remains in its infancy, the
study of genetic variants will be substantially aided by
the extended genomic coverage offered by GWAS.
GWAS offers great benefit primarily through its use of
large numbers of common genetic variants that can aid
in the identification of relevant biological mechanisms
of the disease. Lately, several approaches have been pro-
posed to facilitate the translation of genetic association
results into hypotheses suitable for further investigation.
Examples include the identification of polygenic models
to study the common contribution of multiple loci to
the risk of the disease [49] as well as network-based
approaches to leverage models of cell regulation and
GWAS data to develop integrative network-based asso-
ciation studies [50]. Finally, to better characterize the
functional relevance of genetic association results, the
integration of common variants with neurobiological
data derived from related experiments on the transcrip-
tome and epigenome of the disease may further our
understanding of the pathogenesis of PTSD.
The fourth conclusion of our review relates to core
methodological issues that beleaguer this body of litera-
ture. Consequently, we are presently unable to draw sub-
stantive conclusions about how GxE factors consistently
affect PTSD. Distilling information across studies, we
are, however, able to describe limitations in this body of
work and then offer steps for how these limitations can
be addressed in future studies. Specifically, the three
most pervasive limitations relate to: 1) measurement of
trauma, 2) ascertainment of PTSD cases, and 2) sample
size. Although the issue of heterogeneity in trauma re-
search is neither new nor simple, it continues to stymie
our understanding of how trauma interfaces with PTSD.
Much previous research has demonstrated that the con-
ditional risk of developing PTSD is dependent on the
nature of the trauma. For example, a meta-analysis by
Ozer and colleagues [51] found that different traumas
are associated with different conditional risks. Such con-
clusions—which demonstrate that all traumas are not
created equal—subsequently highlight the inherent prob-
lem with treating disparate traumatic events as similar
points of comparison. In the current review, not only are
there comparisons of diverse traumatic events across
studies (e.g., flood [52] vs. genocide [53]), but there is
also considerable variability within studies. For example,
Valente and colleagues [54] grouped many forms of
trauma within a single study without discrimination
(e.g., robbery, domestic violence, witnessing violence).
Furthermore, in addition to different events being
associated with different conditional risk, research has
similarly demonstrated that psychopathology is also
dependent on the duration of the traumatic event(s).
Chronic trauma exposure, for example, has been asso-
ciated with greater psychopathology than an acute ex-
posure [55]. Despite this information, only 17 studies
assessed for multiple traumas. Moreover, only one study
assessed for a dose–response relationship [44].
Just as chronicity of trauma affects symptom constella-
tions, so too does the timing of trauma along the devel-
opmental continuum (i.e., childhood vs. adulthood). The
vast majority of studies did not examine whether GxE
effects differed across the developmental continuum. In
fact, only four studies assessed how childhood trauma
interacted with genetics to predict adult PTSD symp-
toms [31,32,56,57]. Examining GxE effects according to
developmental timing of trauma exposure is important
not only because the association between particular
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because exposure to childhood trauma may heighten
risk for onset of PTSD following secondary trauma [25].
For example, with regard to developmental timing, al-
though Binder and colleagues [31] found no main effects
of FKBP5 SNPs on PTSD, they did find a significant
interaction between four FKBP5 SNPs and severity of
child abuse on adult PTSD symptoms. Interestingly,
while none of these four articles found a main effect for
genotype, all found a significant GxE interaction, again
underscoring how analysis of the GxE relationship is im-
perative for gaining a more robust understanding of
PTSD’s etiology.
As trauma is a necessary precursor to PTSD, it follows
that a lack of continuity in our operationalization of
trauma would cause similar disruptions in our under-
standing of PTSD. Caseness of a PTSD is another serious
confound that limits the breadth of our conclusions.
Across these 28 studies, individuals selected into the
PTSD case group likely had a mix of PTSD statuses.
While some individuals suffered from chronic or acute
PTSD, others were likely in remission. As previously noted
by Cornelis and colleagues [11], genetic influences may
differ for current vs. lifetime PTSD. They suggested that
making the distinction between lifetime and current PTSD
in genetic studies may be important for case definition. In
our review, only 18 articles reported whether participants
had current or lifetime PTSD. Of the 18 available, seven
included participants with only current PTSD. Further
complicating the issue of caseness, the method and cri-
teria by which PTSD was assessed varied markedly. Some
studies used self-report questionnaires [47], whereas
others used formal clinical interviews [56].
PTSD itself is a heterogeneous phenotype. Comprised
of 17 symptoms, several of the symptoms—like Cluster
B’s intense distress at reminders of trauma and Cluster
C’s feelings of numbness—are markedly distinct from
each other. Empirical investigation into the distinct
symptom presentations has indicated that individuals
diagnosed with PTSD often have heterogeneous clinical
presentations [58,59]. In the context of a review on
PTSD’s genetic underpinnings, the idiosyncrasies in
symptom presentations raise questions about the under-
lying genetic mechanisms. As the symptom phenotypes
can be markedly distinct, it is possible that their corre-
sponding genetic substrates would also be different.
Findings from some of the studies are consistent with
this hypothesis. Dragan and colleagues found that at
least one copy of the DRD4 long allele related to Avoid-
ance/Numbing scale (and Total PSTD score) but not to
other symptom clusters. Likewise, Bailey and colleagues
found moderate heritabilities of PTSD diagnosis and C
category symptoms, and high heritabilities of B symptom
categories [60].
The third major methodological limitation relates to
sample size. Virtually all studies were obstructed by in-
sufficient sample sizes. Factors impacting power to de-
tect main genetic effects will also apply to tests for G ×
E interactions. The prevalence and effect of the environ-
mental pathogen, as well as the type and size of inter-
action effect will also determine study power. A
heuristic is that a fourfold increment in sample size is
needed to examine multiplicative interactions between
two main effects [61].
As a result of the aforementioned limitations (i.e.,
operationalization of trauma, PTSD caseness and sample
size), different configurations of genetic risk based on ei-
ther allele or genotype, and the direction of the associ-
ation, there are contradictory results across various
studies. For example, Segman and colleagues found that
DAT is related to PTSD, while Bailey and colleagues did
not. In the first study, the authors showed a significant
association of the homozygote genotype for the 9 repeats
allele (9/9) with PTSD, while in the second study a sim-
ple allelic association of the 9 repeats allele was tested
and did not reach statistical significance. Likewise,
Gelernter and colleagues [43] did not find any associ-
ation between DRD2 and PTSD, while Comings and col-
leagues did [42]. In the first study, the authors reported
a lack of association when comparing D2A1 carriers (i.e.,
D2A1/ D2A1 plus D2A1/ D2A2 subjects) and D2A2
homozygotes. In the conclusions of Comings and collea-
gues, the positive finding was reported for the allelic as-
sociation with PTSD of D2A1 carriers as opposed to the
non-carriers. Even more complex is the scenario of asso-
ciation studies on the 5-HTTLPR polymorphism of the
serotonin transporter (SLC6A4). Different configurations
of the genetic risk were considered in the analyses. Some
studies compared the rates of the three genotypes ss/sl/ll
[36,46,53]; others tested differences between the group
of carriers of the ll genotype and the group of sl and ll
genotype carriers [40]. Yet still others considered allelic
associations--either s or l alleles—separately [62]. Several
studies modeled the genotypic configuration based on
the independent contribution of the 5-HTT functional
expression alleles, which groups the s and lg (i.e. the
diplotype constructed with the l allele of 5-HTTLPR and
the g allele of the A/G SNP rs25531 within the 5-
HTTLPR insertion) as the low expression functional
alleles [63,64]. Differences in the direction of the allelic
association have also been reported. Some studies
reported association of the s allele with PTSD [29,57],
while others the l allele [62]. A meta-analysis would be
highly recommended to derive more robust conclusions
about the association of 5-HTTLPR with PTSD. Overall,
these examples underlie that determining whether the
inconsistencies across studies are a result of differences
in the genetic risk definition or a true lack of replication
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results underscore the need to attend to these differ-
ences for not only interpretative purposes but also as a
method of progress in the field of PTSD genetics. Des-
pite its limitations, the available literature does raise
compelling questions about the importance of studying
the GxE relationship in the context of PTSD.
Current challenges & future directions
It is hoped that the review of these 28 articles has illumi-
nated important questions that future studies may seek
to answer. In addition to the four aforementioned con-
clusions that were predicated on information included in
these 28 studies, this review also offers two main guide-
lines for future studies. First, we suggest a framework for
future studies that will allow for the systematic examin-
ation of data in a more standardized way. Specifically, an
analytical approach that clearly provides information on
the GxE interaction as well as the main effects of both
trauma and genotype on PTSD would be of great benefit
in gaining a more precise understanding of nature of this
relationship. Likewise, future studies should also con-
sider the effects of ethnic differences in allele frequency
and, subsequently, the consequences that such popula-
tion stratification may have on understanding the risk
for and etiology of PTSD.
Second, it is also hoped that the findings from this
review inform future study in this area. For example,
future hypothesis-free, genome-wide genetic studies will
be of great import in fostering a deeper understanding
of PTSD’s etiology. Additionally, studies will be aided by
incorporating more precise measures of environmental
factors. For example, more explicit information on: 1)
the specific nature of the index trauma; 2) when the
index trauma occurred in the context of development; 3)
the number of lifetime traumas, and 4) the chronicity
versus acuity of PTSD in the sample would represent an
important contribution in our understanding of environ-
mental stress and, subsequently, how it interfaces with
genotype. Moreover, advances in our understanding of
the relationship between genetics and environment will
be enhanced by future studies that explore—not only the
GxE relationship—but also the more complex GxGxE
and GxExE relationships. Exploration of interactions be-
yond the GxE relationship will almost certainly elucidate
more about PTSD’s intricate and multifactorial etiology.
Likewise, efforts to elucidate the causality in these inter-
actions as well as the molecular mechanisms behind
them will do much to further our understanding of the
psychopathology. Finally, functional studies that examine
the downstream consequences of the GxE interaction on
biological pathways will also aid in our understanding
of the etiology. Although the clinical applications of
GxE research are presently remote, gaining a deeper
understanding of how genetic and environmental risk
factors contribute to the disorder will allow for more
effective predictions, evaluations and, ultimately, treat-
ment of PTSD.
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